Skip to main content

Moderna gets full US approval for COVID shot in at-risk children 6 months and older

Coronavirus,Coronavirus Vaccine,Vaccines,FDA

From the Center

The U.S. Food and Drug Administration has granted full approval for Moderna's (MRNA.O), opens new tab COVID-19 vaccine, Spikevax, in children aged 6 months through 11 years who are at an increased risk of the disease, the company said on Thursday.

AllSides Picks

More News about Coronavirus

News from the Left

News from the Center

News from the Right